NCT03198468View on ClinicalTrials.gov

Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE)

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 21, 2018

Primary Completion Date

August 20, 2019

Study Completion Date

August 20, 2019

Conditions
Non Small Cell Lung CancerMetastatic Lung CancerLung Cancer
Interventions
DEVICE

Bronchoscopic Thermal Vapor Ablation

Vapor (steam) is infused into the targeted region for 8 seconds at a precisely controlled flow rate and power (an energy level of 330 calories).

Trial Locations (1)

3050

The Royal Melbourne Hospital, Melbourne

All Listed Sponsors
lead

Uptake Medical Technology, Inc.

INDUSTRY

NCT03198468 - Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE) | Biotech Hunter | Biotech Hunter